通过Chryseobacterium sp.阐明多克西环素生物转化机制 WX1:多omics洞察力的洞察力
Xiuli Chen1, Ying Zhu1, Wenli Zheng2
1State Key Joint Laboratory of Environmental Simulation and Pollution Control, College of Environmental Sciences and Engineering, Peking University, Beijing 100871, China.
Journal of hazardous materials
|March 7, 2024
概括
一种新型的细菌,Chryseobacterium sp. 这是一种新型的细菌. WX1,可以完全降解多西环林 (DOX),一个持久的环境污染物. 这一发现为从废水处理系统中去除DOX提供了一个有希望的生物解决方案.
科学领域:
- 环境微生物学 环境微生物学
- 生物修复是一种生物修复.
- 抗生素耐药性 抗生素耐药性
背景情况:
- 东环素 (DOX) 是一种广泛使用的抗生素,也是持续性环境污染物.
- 关于DOX.的微生物降解的知识有限.
- 需要有效的废水中DOX的去除策略.
研究的目的:
- 为了分离和描述能够降解多克西环素的细菌.
- 为了阐明代谢途径和DOX降解的遗传基础.
- 评估已识别的细菌在废水处理中的潜力.
主要方法:
- 从活性污泥中分离了DOX降解细菌.
- 化学分析以确定生物转化产品.
- 多组学方法 (基因组学,转录组学,蛋白质组学).
- 在体外异质表达测试用于基因功能验证.
主要成果:
- 克里西奥细菌 (Chryseobacterium sp.) 的分离 WX1,能够在44小时内完全降解50mg/L的DOX.
- 确定七种生物转化产品,从DOX氧化开始.
- 鉴定了tetX基因对于初始DOX氧化至关重要.
- 分解途径的解,涉及微生物运输,酶合成和能量代谢.
结论:
- 克里西奥细菌 (Chryseobacterium sp.) 是一种细菌 WX1具有完全降解多西环林的独特能力.
- X基因和相关酶在DOX生物转化途径中发挥关键作用.
- 这种菌株显示出在污染废水处理系统中增强DOX去除的巨大潜力.
相关概念视频
Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...


